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Mice that lack the DNA demethylases TET2 and TET3 in their T cells show proliferation of 
innate-like (memory) CD8 cells. These activated innate-like cells have effector properties that 
are critical in fighting viral infections and suppressing the expansion of tumor cells. However, 
the gene expression program and subsequent molecular mechanisms underlying this lineage-
skewing were unknown. Flow cytometry analysis of TET2/TET3 double-knockout (DKO) CD8 
cells in mice established that upregulation of the transcription factor Eomes results in innate-like 
CD8 programming. By utilizing RNA-sequencing and differential expression analysis, we 
compared the gene expression programs of TET2/TET3 DKO CD8 cells with both wild-type 
CD8 cells and innate-like CD8 cells that overexpress Eomes. We observed noticeable overlap in 
the significantly differentially expressed genes and enriched pathways between the DKO and 
EomesTG mice in comparison to controls. In addition, we determined the key pathways and gene 
ontologies that were overrepresented in the DKO mice. Our results suggest that Eomes 
overexpression and TET2/TET3 deletion in CD8 cells share similar molecular mechanisms of 
innate-like expansion. We also discovered that genes unique to the TET2/3 DKO mice were 
highly enriched in cancer-related pathways. Further research into specific dysregulated genes we 
discovered is needed to understand how this lineage-skewing takes place. 
Introduction: 
 The foundation of gene expression in mammalian cells is the activation of specific genes 
in certain cell types. When lineage-specifying transcription factors (TFs) bind to their related 
promoters, cells generate transcripts that cause them to differentiate into new subtypes. This 
process is both temporally and spatially specific, as cells in varying regions of the body express 
TFs when exposed to certain environmental stimuli at different times.  
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 The discovery of the epigenome in the last several decades has expanded the complexity 
of cellular and molecular biology. Epigenetic marks regulate access to gene sequences by 
physically altering the structure of the histones surrounding the DNA or even the DNA itself. 
Histone post-translational modifications and DNA methylation are two of the primary 
modifications that can occur1. In mammalian cells, methylation of DNA occurs on cytosine bases 
at CG dinucleotides, which are known as CpG islands1. It was recently discovered that 
methylation of CpG islands is a reversible process independent of dilution through DNA 
replication2.  
 A family of DNA demethylases known as ten eleven translocation proteins (TET) have 
been shown to catalyze the oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine 
(5hmC) and further derivatives, eventually leading to unmodified cytosine3. The three proteins in 
this family, TET1, TET2, and TET3, are of additional interest because of their function as tumor 
suppressors. Studies have found TET1 and TET2 to be tumor suppressors of B cell lymphomas 
and malignancies4,5. TET2 also appears to have additional tumor suppressor roles beyond its 
catalytic function6. Mutations in DNA methyltransferases, a family of enzymes that catalyzes the 
addition of methyl to CpG islands, have been causally associated with cancerous malignancies7. 
In a similar vein, it has been shown that TET2 is commonly mutated in hematopoietic cancers 
such as myelodysplastic syndromes, myeloid malignancies8–10, and peripheral T cell 
lymphomas11–13, and mutations in all the TET proteins have been reported in many different 
cancer types1.  
TET proteins are large, multi-domain enzymes with a core catalytic region at the C-
terminus and a CXXC DNA binding domain on the N-terminus (except for TET2)1. Depending 
on the cell type, each of the TET proteins show different expression levels throughout 
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development; TET1 and TET2 are highly expressed in embryonic mouse cells, while TET2 and 
TET3 are highly expressed in differentiated tissues14. In T-cells, our cells of interest, TET3 is 
most highly expressed and TET2 is also abundantly expressed, whereas TET1 is the least 
expressed14. Interestingly, TET3 knockouts in mice have shown 100% lethality15, while 
individual deletion of TET1 or TET2 does not result in any observable developmental 
phenotypes16,17.  There is indication that the proteins have differing, non-redundant functions, 
although it appears that deletion of one of the types can be compensated for by increased 
expression of the others18. Thus, we hypothesize that TET proteins exert shared regulatory 
functions.  
TET proteins are critical in modulating 5hmC enrichment in T cell development and 
lineage specification19. Specifically, 5hmC enrichment increases in the gene body of the CD8 
lineage-specifying TF RUNX3 during the cell stage in which RUNX3 is expressed19. TET2 KO 
in murine T cells has been shown to skew lineages toward innate-like (memory) CD8 cells20. 
Flow cytometry analysis of TET2/3 double knockout (DKO) mice has also shown upregulation 
of the TF Eomes21, which regulates CD8 differentiation into memory cells22. However, the 
transcriptional landscape of TET2/3 DKO CD8 cells is not well understood. To understand the 
effects of TET deletion on CD8 differentiation, we conducted RNA-seq on TET2/3 DKO CD8 
cells harvested from the mouse thymus. To isolate the contributions of TET deletion and Eomes 
expression toward the TET2/3 DKO phenotype, we conducted differential gene expression and 
GO/pathway enrichment analysis of both TET2/3 DKO and transgenic mice with Eomes 
upregulation(EomesTG)23. Our results offer new insights into the shared and unique dysregulated 
genes and pathways between TET2/3 DKO and EomesTG CD8 cells. We found high overlap 
between differentially expressed genes in the two groups, indicating that TET2/3 DKO triggers 
5 
 
differentiation into the innate-like phenotype. We also discovered that genes unique to the 




Figure 1. Data Analysis Pipeline.  
Mouse Models and Library Preparation: 
 The wildtype and DKO mice were developed and raised at the La Jolla Institute as 
described here.21 Wildtype and DKO CD8 cells were extracted from the thymus and sorted with 
fluorescence-activated cell sorting (FACS). Total RNA was extracted using the QIAGEN RNA 
plus kit. The cDNA libraries were prepared for sequencing using the TruSeq kit (Illumina) based 
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on the manufacturer’s instructions. The libraries were sequenced by the Illumina HiSeq 2500 
instrument.21 
 EomesTG mice were generated by the Istaces group by overexpressing Eomes in T cells23. 
Further details regarding the care and sequencing of the samples can be found in their 
publication.23 
Data Acquisition: 
Following sequencing, the raw reads were deposited into the NCBI’s Gene Expression 
Omnibus (GEO)24 with the accession number GSE6683421,25. Additional samples were gathered 
from the publicly accessible paper by Istaces et al. with accession number GSE12491423,26. All 
files were downloaded to a local machine using the Linux version of the SRA Toolkit27. Single-
end read data from our experiment included 3 WT CD8 mice and 4 TET2/3 DKO mice. Paired-
end read data from the Istaces paper included 3 WT CD8 mice and 3 EomesTG mice.  
Quality Control and Transcript Quantification: 
A preliminary assessment of data quality was conducted on each of the raw reads using 
FastQC28 and MultiQC29. All samples had reasonable base and sequence quality as measured by 
FastQC28 and therefore used in the analysis. The pseudoaligner Salmon30 was used to quantify 
transcript expression directly from the RNA-seq reads without prior alignment. Further details 




Transcript abundance outputs were imported with annotated metadata into R using the 
package tximeta31. Each dataset was prefiltered to exclude genes with 0 expression. Four paired 
differential experiments were created from the four data sets as seen in Table 1. 
 
 Table 1. Summary of experimental setup. WT_A refers to wildtype mice from the Tsagaratou 
experiment.21 WT_B refers to wildtype mice from the Istaces experiment.23 
 
In order to conduct gene clustering and principal component analysis (PCA), variance-
stabilizing transformation (VST)32 was applied to each data set to create new data that have a 
stable variance for all genes, regardless of count. This log-transformed data was used to create 
sample distance plots and clustered gene heatmaps that showed the highest variance across 
samples. A PCA plot was also generated to understand how each condition clustered within each 
data set. R libraries used include RColorBrewer33, pheatmap34, and ggplot235.  
Differential gene expression analysis was conducted using the R package Deseq236. The 
differential genes were annotated with gene symbols and Entrez IDs using the R package 
AnnotationDbi.37 These results were exported for downstream GO and pathway enrichment 
analysis. An MA plot of the differential expression data that had been shrunk with the apeglm38 
library was generated for visualization purposes.  
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From experiments 1 and 2, differentially expressed genes with an adjusted p-value 
(padj)39 < 0.1 were imported into a Python Jupyter Notebook40. Python set operations were used 
to find the overlapping and unique genes expressed by the DKO and Eomes mice.  
Gene Ontology (GO) and Pathway Enrichment Analysis:  
 Enrichr41 was used to conduct an enrichment analysis of GO terms among the 
differentially expressed genes for all 4 experiments. For each experiment, the top 2000 
differentially expressed genes (ranked by padj) were selected to determine the enriched GO 
terms in each of the 3 main GO categories defined by the GO Consortium42,43 as of 2018: 
molecular function, cellular component, and biological process. The enriched pathways from the 
KEGG44–46 Mouse 2019 database were also found. Enriched KEGG pathways were also found 
for the intersecting and unique differentially expressed genes. 
 A Gene Set Enrichment Analysis (GSEA) of pathways from the KEGG 2019 database 
was conducted using WebGestalt 201947. For each experiment, all genes with expression > 0 and 
their associated Wald statistic were used to maintain the same order as the padj and the original 
direction of expression of the log fold change.  





Figure 2. The RNA-sequencing data quality is high across samples. A) Summary of Quality 
Control metrics from MultiQC. SRR19- samples are from the Tsagaratou experiment21. SRR84- 
samples are from the Istaces experiment23. B) Phred quality score (Q) measures base calling 
accuracy according to base-calling error probability P with the equation: Q = −10log⁡(P). C) 
Modal GC content from the observed data is used to build a reference distribution against which 
fitting is measured. 
 To determine if the cDNA libraries were sequenced accurately, we assessed data quality 
of the reads. Quality control with FastQC and MultiQC indicated that data from both studies 
were of sufficient quality. All samples had acceptable average read quality with mean Phred 
score > 27 (Figure 2B). Some of the paired-end samples had poor individual base call quality 
(Figure 2A), but each sample had one paired-end read of acceptable quality (mean Phred score > 
25). Use of paired-end reads for those samples reduced error in downstream analyses. No 





Figure 3. Samples cluster according to their genotype. All data were transformed using VST32. 
The principal component that represents the greatest variance is on the horizontal axis. 
“Experiment” refers to the comparisons found in Table 1. A) WT_A vs. DKO. B) WT_ 
A vs. EomesTG. C) DKO vs. EomesTG. 
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 After matching reads to transcripts with Salmon, we used clustering on the VST-
transformed expression data to compare the different sequencing runs. PCA reduced the 
dimensionality of large data sets into two principal components such that similar samples could 
be clustered together. The horizontal axis, principal component 1, showed the greatest difference 
between samples. Ideally, samples of a given genotype will horizontally cluster together with 
some vertical variance (as described by the vertical axis). In each experiment, we observed this 
trend; samples of a given genotype clustered together along the horizontal axis, completely 
separately from the other genotype (Fig. 3). This improved the power of the differential 








Figure 4. The transcripts with the highest variance across samples cluster by genotype. 
Clustered heatmaps represent the top 20 genes from each experiment with the highest variance 
across samples. Unidentified transcripts were excluded. Transcripts with no measured expression 
in most samples were excluded. Raw data were transformed using the VST32. Scale bar indicates 
logarithmic expression (base 2) within a given sample relative to the mean expression across all 
samples. A) WT_A vs. DKO. B) WT_A vs. EomesTG. C) DKO vs. EomesTG. 
 Clustered heatmaps offered another way to understand the relationships between samples 
before conducting the differential expression analysis, and they indicated key genes with large 
expression differences across samples. Samples of a given genotype clustered together separately 
from the comparison genotype as expected (Fig. 4A-C). One key gene was Eomes (Fig. 4A), 
which is highly expressed in the DKO mice compared to the wildtype mice. These results 
confirm previous flow cytometry data demonstrating Eomes upregulation. Notably, many genes, 
such as Rps27rt and Rpl17-ps3, were ribosomal proteins (Fig. 4B/C), indicating a potential 










Figure 5. Significant differential expression occurs in genes across a range of expression levels. 
The DESeq2 method was used in each experiment. Adjusted p value is equivalent to the false 
discovery rate (FDR) as defined by Benjamini and Hochberg39. Genes with padj < 0.1 are 
colored blue. LFC is log2 fold change. Bayesian log fold change shrinkage was applied to each 
DESeq experiment using the R package apeglm.38 In each case, the first genotype is the 
reference, and the second genotype is the comparator. Positive LFC indicates higher expression 
in the comparator, negative LFC indicates higher expression in the reference. A) WT_A vs. 
DKO. B) WT_A vs. EomesTG. C) DKO vs. EomesTG. D) Summary of DESeq results. 
 To understand the differences in gene expression between each of our samples, we 
conducted differential expression analysis using DESeq2. MA plots provided a high-altitude 
view of the results of each comparison (Fig. 5A-D). Significantly differentially expressed genes 
ranged from 20% to over 40% of total expressed genes in each experiment. We observed many 
significant genes with an LFC magnitude greater than 10 (Fig. 5B/C). However, it is likely that 
most of these were artifacts from ribosomal proteins observed in upstream analyses. For each 




Figure 6. A large fraction of differentially expressed genes overlaps between DKO and EomesTG 
mice. Differentially expressed genes were tabulated from Experiments 1 and 2 (both with WT_A 
as the reference) and compared with Python set operations. Venn diagram was constructed with 
several Python packages.48–50 
 To directly compare the DKO and EomesTG mice, we created sets of the significant genes 
from Experiments 1 and 2. Then, we conducted set operations to determine the fraction of shared 
and unique genes. There was a sizable overlap of differentially expressed genes between the 
DKO and EomesTG mice. More than 2/3 of the genes in DKO mice were shared with EomesTG 
mice. However, the remaining third of genes in DKO mice are unique. Once again, the increased 
number of genes for the EomesTG mice could be partially related to the abundance of ribosomal 
transcripts. 
 
Figure 7. GO enrichment occurs primarily in the Biological Process category in each 
experiment. Enriched terms were determined using the hypergeometric test on the Enrichr41 site. 
The top 2000 genes as measured by padj were included for each test. A) WT_A vs. DKO. B) 









Figure 8. GSEA reveals highly enriched pathways from each experiment. Enriched KEGG 
Pathways as determined by GSEA via WebGestalt47. All genes with measured expression and 
their associated DESeq Wald Statistic were incorporated into the test. A) WT_A vs. DKO. B) 
WT_A vs. EomesTG. C) DKO vs. EomesTG. 
  
 The DESeq results were used to determine enriched GO terms and pathways with both 
pathway enrichment and GSEA analyses. Experiments 1 and 2 had many upregulated and 
downregulated significant pathways (Figures 8A/B). This indicated the dissimilarity between 
both experimental genotypes and the wildtype mice. However, we observed no enriched 
pathways for the DKO cells (Figure 8C), more evidence that the DKO cells and EOMES cells 








Figure 9. DKO and EomesTG CD8 cells share many pathways but still have distinct differences. 
Unique and intersecting genes from Figure 6 were run through three separate Enrichr KEGG 
Mouse 2019 Pathway enrichment analyses. Pathways with padj < 0.1 were included in the bar 
graphs. Larger bar indicates a lower padj. Genes and their associated statistics were taken from: 
A) Overlap of DKO and EomesTG. B) Unique EomesTG. C) Unique DKO. 
 Pathway analysis offered insight into the similarities and differences between the DKO 
and EomesTG mice (Fig. 9A-C). Of the pathways unique to the DKO mice, half (4 of 8) were 
directly related to cancer (Figure 9C). Many of the Eomes pathways were related to cellular 
trafficking, cell signaling, and RNA metabolism. We found more significant shared pathways 
than unique ones, indicating the similarity between the DKO and EomesTG mice. 
Discussion: 
 Differential expression analysis revealed the gene expression programs of TET2/3 DKO 
and EomesTG CD8 cells in mice. When individually comparing each experimental group to WT 
mice, the number of significantly differentially expressed genes ranged from 20% to 40% of all 
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measured transcripts (Fig. 5D). This indicates meaningful skewing from the normal CD8 lineage. 
A comparison of differentially expressed genes from DKO and EomesTG mice showed a high 
level of overlap between the two groups (Fig. 6). In addition, GSEA of DKO and EomesTG 
samples did not find any pathways overrepresented only in the DKO mice (Fig. 8C). These data 
provide evidence that removal of TET2/3 and overexpression of Eomes result in similar skewing 
of the transcriptional landscape in CD8 cells. This follows from previous flow cytometry data21 
that showed overexpression of Eomes in DKO cells.  
We should also note that there were many unique genes for both genotypes (Fig. 6). This 
supports the idea that while these experimental groups are broadly similar, some key 
differentially expressed genes result in meaningful phenotypic differences. One example of this 
is the relationship between TET mutations and hematopoietic cancers. TET mutations in somatic 
cells, especially in TET2 and TET3, are often early-stage mutations that increase risk for 
hematopoietic cancer1. Pathway enrichment of only the significant, unique genes in the DKO 
samples revealed eight enriched pathways, four of which were directly related to cancer  (Fig. 
9C). While the EomesTG mice did not develop cancer23, many of the DKO mice did21. The genes 
that comprise those four enriched cancer pathways may be related to the mechanism by which 
TET mutations lead to downstream malignancies.  
We would like to note some potential caveats and shortcomings of our experiments. The 
first and most important is that our number of replicates for each genotype was quite low. 
Although DESeq2 has methods for improving the variance of gene expression distributions with 
low sample counts and thereby improving statistical power36, these techniques are inherently 
limited and cannot truly replace larger sample sizes. In addition, some of the reads used from the 
Istaces experiment were not of the highest quality; ideally both paired-end reads from a given 
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sample would have been close in quality instead of vastly disparate. Since these samples were 
used from a public database, this was not something we could control or change. Lastly, results 
from Enrichr analysis can vary due to the arbitrary selection of inputs. Since this method can 
take a gene list of any length without an associated statistic (unlike GSEA, which requires the list 
of all genes from an experiment with their associated statistic), there is no standard for choosing 
the input size. Other list lengths may have produced differing results. 
The datasets, gene lists, and enriched pathways generated by this work represent  an 
important step forward in understanding the transcriptomic profile of TET2/3 DKO CD8 cells. 
Future directions in this work will require more sophisticated technological and analytical 
techniques. Single-cell RNA-seq of both non-malignant/pre-malignant and malignant TET2/3 
DKO cells could provide better insight into the changes that cause cells with TET mutations to 
become cancerous. There are opportunities to go beyond our approaches as well. Genomics 
experiments are often described as hypothesis-generating, and this study follows that trend. 
While providing answers about which genes DKO and EomesTG mice share to produce an innate-
like phenotype, this study also offers new starting points for understanding the mechanisms 
behind mutant TET malignancy. Further lab experiments focusing on the unique dysregulated 
genes in the cancerous pathways identified in the DKO mice could more clearly elucidate TET’s 




The Salmon version used was v1.3.0. The mouse Ensembl transcriptome was retrieved 
from: https://github.com/pachterlab/kallisto-transcriptome-indices/releases with filename 
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Mus_musculus.GRCm38.cdna.all.fa. This transcriptome was used to build a Salmon index with 
the command salmon index. Salmon quant was run in mapping-based mode with the following 
parameters: -l A, --validateMappings, --gcBias.  
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